Plus Therapeutics (PSTV) Misses Q2 EPS by 71c
Tweet
Share
E-mailGet Alerts PSTV Hot Sheet
Join SI Premium – FREE
Plus Therapeutics (NASDAQ: PSTV) reported Q2 EPS of ($0.71). Revenue for the quarter came in at $1.27 million.
For earnings history and earnings-related data on Plus Therapeutics (PSTV) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- KB Home (KBH) Tops Q3 EPS by 16c
- United Parks & Resorts promotes Miller to president, Maupin to COO
- Parke Bancorp (PKBK) Declares $0.20 Quarterly Dividend; 2.4% Yield
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
